On Invalid Date, Windtree Therapeutics (NASDAQ: WINT) reported Q4 2023 earnings per share (EPS) of -$13.32, up 93.98% year over year. Total Windtree Therapeutics earnings for the quarter were -$5.15 million. In the same quarter last year, Windtree Therapeutics's earnings per share (EPS) was -$221.22.
As of Q2 2024, Windtree Therapeutics's earnings has grown year over year. Windtree Therapeutics's earnings in the past year totalled -$20.29 million.
What is WINT's earnings date?
Windtree Therapeutics's earnings date is Invalid Date. Add WINT to your watchlist to be reminded of WINT's next earnings announcement.
What was WINT's revenue last quarter?
On Invalid Date, Windtree Therapeutics (NASDAQ: WINT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Windtree Therapeutics's revenue was $0.00.
What was WINT's revenue growth in the past year?
As of Q2 2024, Windtree Therapeutics's revenue has grown null year over year. Windtree Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.